Evaluation of Nutritional Status and Fatigue in Patients With Multiple Sclerosis
NUTRISEP
Evaluation of the Nutritional Status of Patients With Multiple Sclerosis and Relationship With Fatigue
1 other identifier
observational
360
1 country
12
Brief Summary
Multiple sclerosis (MS) is a chronic progressive neurological disease, the leading cause of disability after injury accidents in young adults. Among the many symptoms, fatigue is very common with a significant impact on quality of life. Also, the disability caused by multiple sclerosis can alter food intake and can cause nutritional deficiencies. Nutrients such as proteins, minerals (iron, calcium, magnesium), some vitamins (B12, 25 OHD) are often deficient in this population with consequences in physical performance such as endurance and muscle strength. We propose to study the link between fatigue and shortcomings encountered in a defined population of MS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Typical duration for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 3, 2013
CompletedFirst Posted
Study publicly available on registry
December 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2017
CompletedAugust 21, 2018
August 1, 2018
3.6 years
December 3, 2013
August 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between the score of fatigue EMIF-SEP and the dosage of nutrients in blood (vitamins, minerals, proteins) adjusted by the EDSS status
The objective is to construct and validate a regression model between the scale of fatigue and biological variables
Baseline
Secondary Outcomes (8)
Presence or absence of sociodemographic variables
Baseline
Presence or absence of clinical manifestations
Baseline
Level of physical activity and daily energy expenditure
Baseline
Assessment of dysphagia according to the score of the Dymus Test
Baseline
Score of the taste sensibility test
Baseline
- +3 more secondary outcomes
Study Arms (1)
Multiple Sclerosis cases
All patients will undergo the following interventions * Gustatory sensitivity test using Taste strips * Blood sampling * Questionnaires
Interventions
A blood sample will be taken from each patient and the following parameters will be assessed : magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.
16 Taste Strips impregnated with 4 flavors (sweet, sour, salty, bitter, each flavor present at 4 different concentrations), are offered to the patient one after the other in a so-called pseudorandomized sequence. The task of the patient is to choose one of the following answers: sweet / sour / salty / bitter / no taste. Each correct answer is granted one point. In addition to the impregnated strips, two tasteless strips can be integrated in the examination at any point of time (no point)
Evaluation of the following parameters by validated questionnaires (name of the questionnaire in bracket): * Fatigue (EMIF-SEP) * Dysphagia (DYMUS) * Food intake (semi-structured questionnaire) * Depression (BDI-II) * Daily energy expenditure (NAP) * Visual analog scale to study quality of sleep
Eligibility Criteria
Patients with MS defined according to the revised diagnostic criteria of Mac Donald, with ages between 18 to 65 years with an Expended disability status scale (EDSS) between 0 and 7 and followed in the services of neurology or physical medicine and rehabilitation.
You may qualify if:
- Patients between 18 and 65 years old
- Expended disability status scale (EDSS) between 0 and 7
- Diagnosis of MS according to the revised criteria of McDonald
- Clinically stable patients in the past 3 months
- Coverage of the social insurance
- Informed consent to participate
You may not qualify if:
- Cognitive disorders that can hinder answering questionnaires
- Presence of uncontrolled metabolic disease(s)
- Malabsorption
- Patients with a gastrostomy
- Active cancer under treatment
- Anorexia
- Pregnancy or breast feeding
- Severe psychiatric disorder(s)
- No informed consent to participate
- No coverage by the social insurance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Centre Hospitalier Universitaire de Caen
Caen, Basse-Normandie, 14033, France
Centre Hospitalier d'Arras
Arras, Hauts-de-France, 62022, France
Centre Hospitalier de Boulogne, Hôpital Duchenne
Boulogne-sur-Mer, Hauts-de-France, 62200, France
Centre Hospitalier de Calais
Calais, Hauts-de-France, 62100, France
Centre Hospitalier de Douai
Douai, Hauts-de-France, 59507, France
Groupement des Hôpitaux de l'Institut Catholique de Lille
Lille, Hauts-de-France, 59000, France
Centre Hospitalier Régional Universitaire de Lille
Lille, Hauts-de-France, 59037, France
Centre Hospitalier de Sambre-Avenois
Maubeuge, Hauts-de-France, 59600, France
Centre Hélène Borel
Raimbeaucourt, Hauts-de-France, 59283, France
Centre Hospitalier Dron de Tourcoing
Tourcoing, Hauts-de-France, 59208, France
Centre Hospitalier de Valenciennes
Valenciennes, Hauts-de-France, 59322, France
Centre Hospitalier Universitaire d'Amiens
Amiens, Picardie, 80054, France
Biospecimen
Biological analysis in serum: magnesium, albumin, Vitamin B12, Vitamin D, Calcium, Iron.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cécile Donzé, MD
Groupement des Hôpitaux de l'Institut Catholique de Lille
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2013
First Posted
December 11, 2013
Study Start
November 1, 2013
Primary Completion
June 9, 2017
Study Completion
June 9, 2017
Last Updated
August 21, 2018
Record last verified: 2018-08